Capital Research holds 4.7M shares of Celanese (CE) in 13G/A amendment

Rhea-AI Filing Summary

Celanese Corp. ownership disclosure: Capital Research Global Investors filed an amendment reporting beneficial ownership of 4,696,916 shares of Celanese common stock, equal to 4.2% (as of 03/31/2026) of the 111,922,758 shares the filer believes are outstanding. The filing attributes sole voting and sole dispositive power over all reported shares to the filer.

Insights

Institutional Ownership Analyst

Large institutional stake disclosed; holdings under 5% threshold.

Capital Research Global Investors reports beneficial ownership of 4,696,916 shares, representing 4.2% of the outstanding common stock as of 03/31/2026. The disclosure consolidates holdings across several investment management entities under the CRGI name.

Filing shows sole voting and sole dispositive power for the reported shares. This is a routine 13G/A disclosure of a passive institutional stake; further activity would appear in subsequent filings if the ownership or intent changes.

Corporate Governance Specialist

Passive ownership near but below the 5% reporting threshold that can trigger different obligations.

The amendment clarifies the organizational structure: CRGI is a division of Capital Research and Management Company and aggregates related investment management affiliates when reporting holdings. The filing repeats the firm’s consolidated beneficial ownership and power breakdowns.

Because the position is 4.2%, it remains classified here as ownership of 5 percent or less; any material change above that level would alter filing obligations.

Key Figures

Shares beneficially owned: 4,696,916 shares Percent of class: 4.2% Shares outstanding (base used): 111,922,758 shares +1 more

4 metrics

Shares beneficially owned 4,696,916 shares reported by Capital Research Global Investors

Percent of class 4.2% of 111,922,758 shares believed to be outstanding

Shares outstanding (base used) 111,922,758 shares figure cited as 'believed to be outstanding' in the filing

Filing signature date 05/11/2026 signature date on the Schedule 13G/A amendment

Key Terms

Schedule 13G/A, beneficial owner, sole dispositive power

3 terms

Schedule 13G/A regulatory

"Capital Research Global Investors filed an amendment reporting beneficial ownership"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

beneficial owner financial

"CRGI is deemed to be the beneficial owner of 4,696,916 shares"

A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.

sole dispositive power financial

"Sole power to dispose or to direct the disposition of: 4,696,916"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Celanese Corp.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

150870103

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 150870103

1

Names of Reporting Persons

Capital Research Global Investors

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 4,696,916.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 4,696,916.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,696,916.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.2 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Celanese Corp.
(b)	Address of issuer's principal executive offices: 222 West Las Colinas Blvd. Suite 900N, Irving, TX 75039, United States of America
Item 2.
(a)	Name of person filing: Capital Research Global Investors
(b)	Address or principal business office or, if none, residence: 333 South Hope Street, 55th Fl, Los Angeles, CA 90071
(c)	Citizenship: N/A
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 150870103
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 4,696,916 ** **Capital Research Global Investors ("CRGI") is a division of Capital Research and Management Company ("CRMC"), as well as its investment management subsidiaries and affiliates Capital Bank and Trust Company, Capital International, Inc., Capital International Limited, Capital International Sarl, Capital International K.K., Capital Group Private Client Services, Inc., and Capital Group Investment Management Private Limited (together with CRMC, the "investment management entities"). CRGI's divisions of each of the investment management entities collectively provide investment management services under the name "Capital Research Global Investors." CRGI is deemed to be the beneficial owner of 4,696,916 shares or 4.2% of the 111,922,758 shares believed to be outstanding.
(b)	Percent of class: 4.2 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 4,696,916
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 4,696,916
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Capital Research Global Investors

Signature:	Jae Won Chung
Name/Title:	Vice President and Senior Counsel II, Capital Research and Management Company
Date:	05/11/2026

FAQ

What stake does Capital Research Global Investors report in Celanese (CE)?

Capital Research Global Investors reports beneficial ownership of 4,696,916 shares, equal to 4.2% of Celanese common stock as reported in the amendment. The filing states the shares are held with sole voting and dispositive power by the filer.

Does the filing indicate Capital Research controls voting of the Celanese shares?

Yes. The amendment states the filer has sole power to vote and sole power to dispose of all 4,696,916 shares reported, with no shared voting or dispositive power listed in the disclosure.

What is the total number of Celanese shares outstanding used in this filing?

The filing cites a share base of 111,922,758 shares believed to be outstanding. The filer calculates its position as 4.2% of that outstanding figure in the Schedule 13G/A amendment.

Is this filing a Schedule 13G/A or a Schedule 13D?

This document is an amendment to Schedule 13G (13G/A), typically used by passive institutional investors to report beneficial ownership when no active acquisition intent is claimed. The filing is signed by an authorized representative.

When was the Schedule 13G/A amendment signed and filed?

The amendment is signed by Jae Won Chung, Vice President and Senior Counsel II, Capital Research and Management Company, with a signature date of 05/11/2026 on the filing covering holdings as of 03/31/2026.